Top compounds associated with response to TTYH3


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.062 0.06
mRNA myriocin CTRPv2 pan-cancer AAC 0.17 0.06
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.06
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.065 0.07
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.063 0.07
mRNA QL-XII-61 GDSC1000 pan-cancer AAC 0.095 0.07
mRNA Rapamycin gCSI pan-cancer AAC -0.12 0.07
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC 0.076 0.07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.07
mRNA KIN001-270 GDSC1000 pan-cancer AAC -0.065 0.07
Download CSV